Immune checkpoint inhibitor treatment of brain metastasis associated with a less invasive growth pattern, higher T-cell infiltration and raised tumor ADC on diffusion weighted MRI.
Rasheed ZakariaMichael D JenkinsonMark RadonKumar DasHarish PoptaniNitika RathiPhilip S RudlandPublished in: Cancer immunology, immunotherapy : CII (2023)
Treatment of a melanoma brain metastasis with ipilimumab appears to cause measurable biological changes in the tumor that can be correlated with post-treatment diffusion weighted MRI imaging, suggesting both a mechanism of action and a possible surrogate marker of efficacy.